ATMU vs BGSI

The company exhibits weak financial health with a Piotroski F-Score of 3/9, indicating significant concerns in profitability, leverage, and operating efficiency. Despite this, Atmus shows strong profitability metrics including an ROE of 71.52% and solid revenue and earnings growth, supported by a bullish analyst recommendation and consistent earnings beats. Valuation is rich relative to Graham’s defensive standard ($14.97 vs. current price of $56.55), but growth expectations justify a premium. However, bearish insider activity and high leverage temper optimism, creating a mixed outlook.

BGSI's Piotroski F-Score of 4/9 indicates weak financial health, signaling deterioration in operational efficiency and profitability trends. The absence of an Altman Z-Score raises concern about bankruptcy risk, especially given a high debt/equity ratio of 1.59 and a current ratio of 0.69, both below safe thresholds. Despite strong earnings growth (284.6% YoY), the company trades at a stretched forward P/E of 39.13 and a current P/E of 218.41, far exceeding sector averages and intrinsic value estimates. The Graham Number ($25.65) and intrinsic value ($21.83) suggest significant overvaluation, with the current price of $161.62 implying a premium driven by speculative growth expectations. Technical trends are bearish, and insider activity is neutral, further undermining confidence.